levofloxacin has been researched along with Sclerosis, Systemic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Horino, T; Ichii, O; Inotani, S; Matsumoto, T; Terada, Y | 1 |
Cervera, R; de La Red, G; Font, J; Lladó, A; Mejía, JC; Mensa, J | 1 |
2 other study(ies) available for levofloxacin and Sclerosis, Systemic
Article | Year |
---|---|
Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome (DRESS/DIHS) caused by levofloxacin in a patient with systemic scleroderma, rheumatoid arthritis, and Sjogren syndrome.
Topics: Aged; Anti-Bacterial Agents; Arthritis, Rheumatoid; Dermatitis, Exfoliative; Drug Hypersensitivity Syndrome; Female; Follow-Up Studies; Herpesvirus 6, Human; Humans; Levofloxacin; Lymphadenopathy; Patch Tests; Rare Diseases; Scleroderma, Systemic; Sjogren's Syndrome; Tomography Scanners, X-Ray Computed; Treatment Outcome | 2019 |
Bilateral Achilles tendinitis with spontaneous rupture induced by levofloxacin in a patient with systemic sclerosis.
Topics: Achilles Tendon; Cyclophosphamide; Drug Therapy, Combination; Follow-Up Studies; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prednisone; Risk Assessment; Rupture, Spontaneous; Scleroderma, Systemic; Severity of Illness Index; Tendinopathy | 2003 |